[Hyperprolactinemia and gynaecomastia induced by benserazide].
H
H
El Otmani
F
F
Moutaouakil
H
H
Fadel
I
I
Slassi
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D001545:Benserazide / Q000009:adverse effects* / Q000627:therapeutic use; D006177:Gynecomastia / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy
D000978:Antiparkinson Agents; D001545:Benserazide